DaVita
DVA
479 hedge funds and large institutions have $11.4B invested in DaVita in 2017 Q4 according to their latest regulatory filings, with 100 funds opening new positions, 116 increasing their positions, 205 reducing their positions, and 60 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 8 → 16 (+8)
67% more first-time investments, than exits
New positions opened: 100 | Existing positions closed: 60
16% more capital invested
Capital invested by funds: $9.81B → $11.4B (+$1.56B)
8% more funds holding
Funds holding: 443 → 479 (+36)
0.52% less ownership
Funds ownership: 86.41% → 85.9% (-0.52%)
24% less call options, than puts
Call options by funds: $95.8M | Put options by funds: $127M
43% less repeat investments, than reductions
Existing positions increased: 116 | Existing positions reduced: 205
Top Buyers
| 1 |
Norges Bank
Oslo,
Norway
|
+$139M |
| 2 |
O
OppenheimerFunds
New York
|
+$113M |
| 3 |
Millennium Management
New York
|
+$87.9M |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$74.5M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$66.2M |
Top Sellers
DVA Hedge Fund Activity: Q4 2017 in Review
479 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in DaVita (DVA) for Q4 2017, worth a combined $11.4B — up 16% from $9.81B a quarter earlier.
Buyers outnumbered sellers: 100 funds opened new DVA positions and 60 closed out — a net gain of 40 holders — while 116 added to existing stakes and 205 trimmed.
The largest buyer was Norges Bank, adding an estimated $139M. The largest seller was Boston Partners, cutting an estimated $262M.
- 479 institutional investors held DaVita (DVA) as of Q4 2017, up from 443 in Q3 2017.
- Funds reported $11.4B of DaVita stock for Q4 2017, up 16% quarter-over-quarter.
- 100 funds opened new DaVita positions in Q4 2017 and 60 closed out, a net change of +40 holders.
- The largest DaVita buyer in Q4 2017 was Norges Bank, an estimated $139M added.
- The largest DaVita seller in Q4 2017 was Boston Partners, an estimated $262M sold.
Based on aggregated 13F filings for Q4 2017.